• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用生物相关溶出度来获得含有难溶性模型化合物的固体剂型的体内-体外相关性。

Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound.

作者信息

Lue Bena-Marie, Nielsen Flemming Seier, Magnussen Thomas, Schou Hanne Mette, Kristensen Kim, Jacobsen Lene Orup, Müllertz Anette

机构信息

Department of Pharmaceutics and Analytical Chemistry, The Danish University of Pharmaceutical Sciences, Copenhagen, Denmark.

出版信息

Eur J Pharm Biopharm. 2008 Jun;69(2):648-57. doi: 10.1016/j.ejpb.2007.12.013. Epub 2007 Dec 25.

DOI:10.1016/j.ejpb.2007.12.013
PMID:18280122
Abstract

The usefulness of selected biorelevant dissolution media (BDM) to predict in vivo drug absorption was studied. Dissolution profiles of solid formulations of a poorly soluble model compound were compared in BDM simulating fasted and two levels of fed state. A non-physiologically relevant medium containing the cationic surfactant, cetrimide, was also investigated. All the media studied were capable of differentiating between the formulations employed, with formulation A consistently ranking high and formulations C and D ranking low. An in vivo dog study was carried out and an attempt was made to obtain a level A correlation between the plasma absorption curves and in vitro dissolution curves, using non-linear regression software. The in vitro-in vivo correlation (IVIVC) models developed indicated that fed state media (BDM 3) containing high levels of both bile salts (BS) and lipolysis products (LP) were best able to predict in vivo pharmacokinetic parameters (Cmax and AUC) with prediction errors lower than 10%. Overall, design and use of appropriate media for in vitro dissolution is extremely important. This study demonstrates the potential of physiologically relevant media containing both BS and LP for use in formulation and early drug development.

摘要

研究了选定的生物相关溶出介质(BDM)预测体内药物吸收的有效性。在模拟禁食和两种进食状态水平的BDM中比较了难溶性模型化合物固体剂型的溶出曲线。还研究了一种含有阳离子表面活性剂西曲溴铵的非生理相关介质。所研究的所有介质都能够区分所用的剂型,其中制剂A始终排名靠前,制剂C和D排名靠后。进行了一项体内犬类研究,并尝试使用非线性回归软件在血浆吸收曲线和体外溶出曲线之间获得A级相关性。所建立的体外-体内相关性(IVIVC)模型表明,含有高水平胆汁盐(BS)和脂解产物(LP)的进食状态介质(BDM 3)最能预测体内药代动力学参数(Cmax和AUC),预测误差低于10%。总体而言,设计和使用合适的体外溶出介质极其重要。本研究证明了含有BS和LP的生理相关介质在制剂和早期药物开发中的应用潜力。

相似文献

1
Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound.利用生物相关溶出度来获得含有难溶性模型化合物的固体剂型的体内-体外相关性。
Eur J Pharm Biopharm. 2008 Jun;69(2):648-57. doi: 10.1016/j.ejpb.2007.12.013. Epub 2007 Dec 25.
2
Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.开发一种用于设计缓释口服剂型的具有生理相关性的群体药代动力学体外-体内相关性方法。
Mol Pharm. 2017 Jan 3;14(1):53-65. doi: 10.1021/acs.molpharmaceut.6b00677. Epub 2016 Dec 12.
3
Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.采用体外-体内模拟方法分析禁食状态下人用非诺贝特脂制剂的口服生物利用度增强。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1274-84. doi: 10.1016/j.ejpb.2013.03.001. Epub 2013 Mar 14.
4
Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.利用生物相关溶出和传递模型试验结合生理相关药代动力学模型预测难溶性、低渗透性弱碱性药物的口服吸收。
Eur J Pharm Biopharm. 2012 Sep;82(1):127-38. doi: 10.1016/j.ejpb.2012.05.008. Epub 2012 May 28.
5
In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media.使用具有生物相关性的溶出介质,采用流通溶出法对难溶性药物达那唑进行体内外相关性研究。
Eur J Pharm Sci. 2005 Mar;24(4):305-13. doi: 10.1016/j.ejps.2004.11.007. Epub 2005 Jan 6.
6
Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.十二烷基硫酸钠对药物-表面活性剂片中难溶性药物在生物相关介质中溶解的影响。
Int J Pharm. 2014 Jun 5;467(1-2):1-8. doi: 10.1016/j.ijpharm.2014.02.043. Epub 2014 Mar 2.
7
Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.预测人体口服米氮平和纳米阿瑞匹坦制剂的体内吸收和食物效应。
Eur J Pharm Biopharm. 2010 Sep;76(1):95-104. doi: 10.1016/j.ejpb.2010.05.009. Epub 2010 Jun 1.
8
Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.禁食状态模拟肠液设计的进展:FaSSIF-V3
Eur J Pharm Biopharm. 2015 Aug;94:229-40. doi: 10.1016/j.ejpb.2015.05.015. Epub 2015 May 29.
9
Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.采用体内-体外-体内模拟方法理解肠溶片剂的体内性能:案例分析双氯芬酸。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1337-47. doi: 10.1016/j.ejpb.2013.09.009. Epub 2013 Sep 18.
10
IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system.使用溶出/渗透系统对非诺贝特速释片口服吸收进行体外-体内相关性研究
J Pharm Sci. 2009 Jun;98(6):2001-9. doi: 10.1002/jps.21576.

引用本文的文献

1
Preparation of Hot-Melt Extruded Dosage Form for Enhancing Drugs Absorption Based on Computational Simulation.基于计算模拟的用于增强药物吸收的热熔挤出剂型制备
Pharmaceutics. 2020 Aug 11;12(8):757. doi: 10.3390/pharmaceutics12080757.
2
Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs.使用基于生理的药代动力学模型进行虚拟群体药代动力学研究,以评估犬口服拉西地平制剂的生物等效性。
Asian J Pharm Sci. 2017 Jan;12(1):98-104. doi: 10.1016/j.ajps.2016.03.003. Epub 2016 Mar 21.
3
Development of in vitro - in vivo correlations for newly optimized Nimesulide formulations.
新型优化尼美舒利制剂的体外-体内相关性研究进展。
PLoS One. 2018 Aug 31;13(8):e0203123. doi: 10.1371/journal.pone.0203123. eCollection 2018.
4
Understanding absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles.理解吸收:监管方面以及应对溶解性和渗透性障碍的当代方法。
Acta Pharm Sin B. 2017 May;7(3):260-280. doi: 10.1016/j.apsb.2016.09.005. Epub 2016 Nov 2.
5
Understanding biorelevant drug release from a novel thermoplastic capsule by considering microstructural formulation changes during hydration.考虑到水合过程中微观结构配方的变化,理解新型热塑性胶囊中生物相关药物的释放。
Pharm Res. 2014 Jan;31(1):194-203. doi: 10.1007/s11095-013-1152-y. Epub 2013 Aug 7.
6
Formulation and evaluation of controlled-release tablet of zolpidem tartrate by melt granulation technique.酒石酸唑吡坦控释片的熔融制粒技术制备及评价
ISRN Pharm. 2011;2011:208394. doi: 10.5402/2011/208394. Epub 2011 Jun 27.
7
Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulations.两种拉莫三嗪片剂制剂的溶出曲线和血清浓度比较。
Drugs R D. 2011;11(1):53-60. doi: 10.2165/11588260-000000000-00000.
8
Multivariate data analysis of factors affecting the in vitro dissolution rate and the apparent solubility for a model basic drug substance in aqueous media.多元数据分析影响模型碱性药物在水介质中体外溶出度和表观溶解度的因素。
Pharm Res. 2010 Jul;27(7):1309-17. doi: 10.1007/s11095-010-0111-0. Epub 2010 Mar 27.
9
The science of USP 1 and 2 dissolution: present challenges and future relevance.美国药典1和2溶出度的科学:当前挑战与未来相关性
Pharm Res. 2009 Jun;26(6):1289-302. doi: 10.1007/s11095-008-9822-x. Epub 2009 Jan 23.